Boston Scientific Corporation NYQ · BSX
Price alert —
Sign in to get a one-time email the moment BSX crosses your price. Free accounts included.
Sign in / create a free accountBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
BSX last traded at $44.03, down 1.3% on the day; that's in the lower part of its 52-week range ($42.20–$94.75). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
The next scheduled earnings report (2026-07-29) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
below KC1 upper, -0.53 ATR from EMA21 — bearish engulfing
- · Stochastic bull cross
- · Counter-trend long in strong downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Bearish engulfing — body fully covers prior green bar
- · Aligned with strong downtrend (strong tailwind)
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
On the latest daily bar, momentum sits mid-range (RSI 42), the trend is strong (ADX 27), and volume is about normal (0.8×). On the business side, revenue is growing 12% year over year and the business keeps about 14 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $42.29 (fair range $38–$43); today's price sits 4% above that estimate. The model's verdict is “Fair” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 69% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.81 (fragile)
Price implies ~12% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
BSX is a $65.4 billion company, priced at 18× last year's earnings, and it moves more calmly than the market (beta 0.6); the stock is trading near the bottom of its 52-week range.
Options idea
See more →Earnings
See more →- Last reported
- 2026-04-22
- EPS (act / est)
- 0.80 / 0.79
- Surprise
- +1.6%
- Next report
- 2026-07-29
About
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced del…